Posts
July 09 2023
RedHill Biopharma Ltd. announced the closing of its Registered Direct offering and Warrant Exercise in the amount of $3,800,000. EG&S acted as counsel to the Placement Agent.
July 09 2023
PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $2,700,000. EG&S acted as counsel to the Placement Agent.
July 06 2023
BioRestorative Therapies, Inc. announced the closing of its Registered Direct offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.
July 05 2023
Delta Corp Holdings Limited and certain of its subsidiaries announced that they closed a revolving credit facility of up to $15,000,000 with a leading US bank on June 29, 2023. The facility is secured by the Company’s working capital. Borrowings under the facility are expected to fund growth in the Company’s Bulk Logistics and Energy Logistics segments and for general corporate purposes. EGS acted as counsel to Delta Corp Holdings Limited.
July 05 2023
REE Automotive Ltd. announced the commencement of its At The Market Offering in the amount of $35,000,000. EG&S acted as counsel to the Sales Agent.
July 02 2023
Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $1,800,000. EG&S acted as counsel to the Placement Agent.
July 02 2023
Cadrenal Therapeutics, Inc. announced the closing of its Private Placement Offering in the amount of $7,500,000. EG&S acted as counsel to the Placement Agent.
June 28 2023
Microbot Medical Inc. announced the closing of its Registered Direct offering in the amount of $2,000,000. EG&S acted as counsel to the Placement Agent.